Daré Bioscience, Inc. (DARE)
NASDAQ: DARE · IEX Real-Time Price · USD
3.630
-0.160 (-4.22%)
At close: Jul 2, 2024, 4:00 PM
3.500
-0.130 (-3.58%)
After-hours: Jul 2, 2024, 7:54 PM EDT

Daré Bioscience Statistics

Total Valuation

DARE has a market cap or net worth of $30.58 million. The enterprise value is $27.83 million.

Market Cap 30.58M
Enterprise Value 27.83M

Important Dates

The next estimated earnings date is Thursday, August 8, 2024, before market open.

Earnings Date Aug 8, 2024
Ex-Dividend Date n/a

Share Statistics

DARE has 8.42 million shares outstanding. The number of shares has increased by 17.54% in one year.

Shares Outstanding 8.42M
Shares Change (YoY) +17.54%
Shares Change (QoQ) +14.81%
Owned by Insiders (%) 1.65%
Owned by Institutions (%) 6.81%
Float 8.28M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 10.86
Forward PS 3.00
PB Ratio n/a
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 9.88
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.56

Current Ratio 0.56
Quick Ratio 0.33
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -139.90%
Return on Capital (ROIC) n/a
Revenue Per Employee $122,486
Profits Per Employee -$1.26M
Employee Count 23
Asset Turnover 0.14
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -66.76% in the last 52 weeks. The beta is 1.35, so DARE's price volatility has been higher than the market average.

Beta (5Y) 1.35
52-Week Price Change -66.76%
50-Day Moving Average 4.65
200-Day Moving Average 4.81
Relative Strength Index (RSI) 33.40
Average Volume (20 Days) 50,526

Short Selling Information

The latest short interest is 172,916, so 2.05% of the outstanding shares have been sold short.

Short Interest 172,916
Short Previous Month 600,187
Short % of Shares Out 2.05%
Short % of Float 2.09%
Short Ratio (days to cover) 0.27

Income Statement

In the last 12 months, DARE had revenue of $2.82 million and -$28.87 million in losses. Loss per share was -$3.84.

Revenue 2.82M
Gross Profit 2.81M
Operating Income -28.58M
Pretax Income -28.87M
Net Income -28.87M
EBITDA -28.77M
EBIT -28.87M
Loss Per Share -$3.84
Full Income Statement

Balance Sheet

The company has $4.39 million in cash and $1.64 million in debt, giving a net cash position of $2.75 million or $0.33 per share.

Cash & Cash Equivalents 4.39M
Total Debt 1.64M
Net Cash 2.75M
Net Cash Per Share $0.33
Equity (Book Value) -11.00M
Book Value Per Share -1.31
Working Capital -7.74M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$29.55 million and capital expenditures -$636,726, giving a free cash flow of -$30.19 million.

Operating Cash Flow -29.55M
Capital Expenditures -636,726
Free Cash Flow -30.19M
FCF Per Share -$3.60
Full Cash Flow Statement

Margins

Gross margin is 99.73%, with operating and profit margins of -1,014.48% and -1,024.93%.

Gross Margin 99.73%
Operating Margin -1,014.48%
Pretax Margin -1,024.93%
Profit Margin -1,024.93%
EBITDA Margin -1,021.40%
EBIT Margin -1,024.93%
FCF Margin -1,071.59%

Dividends & Yields

DARE does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -17.54%
Shareholder Yield -17.54%
Earnings Yield -94.42%
FCF Yield -98.72%

Analyst Forecast

The average price target for DARE is $4.50, which is 23.97% higher than the current price. The consensus rating is "Strong Buy".

Price Target $4.50
Price Target Difference 23.97%
Analyst Consensus Strong Buy
Analyst Count 2
Revenue Growth Forecast (5Y) 163.41%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

The last stock split was on July 1, 2024. It was a reverse split with a ratio of 1:12.

Last Split Date Jul 1, 2024
Split Type Reverse
Split Ratio 1:12

Scores

DARE has an Altman Z-Score of -26.21. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -26.21
Piotroski F-Score n/a